Pharma Journalist 9017 posts 0 comments

CureVac N.V. announced that the first participant was dosed in the Phase 1 part of a combined Phase 1/2 study of multivalent, modified mRNA seasonal flu vaccine candidates, developed in…
Read More...

ProMIS Neurosciences Inc., a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases…
Read More...

Roche announced today the launch of the Institute of Human Biology (IHB) focussing on advancing research in the field of human model systems such as organoids. Leveraging human model…
Read More...

Amphista Therapeutics announced the delivery of the first discovery milestone under its collaboration and license agreement with Bristol Myers Squibb, triggering a payment for achieving…
Read More...

ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs announced the closing of its €42 million…
Read More...

GSK plc announced that the US Food and Drug Administration (FDA) has approved Arexvy (respiratory syncytial virus vaccine, adjuvanted) for the prevention of lower respiratory tract…
Read More...

Forge Biologics announced a gene therapy development and manufacturing collaboration with Labcorp. As a result of this strategic collaboration, gene therapy clients across the…
Read More...

Kamada Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved its application to manufacture CYTOGAM (Cytomegalovirus Immune Globulin Intravenous ) (CMV-IGIV) at…
Read More...

Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, is pleased to announce that it has closed on an important land purchase in Wallonia, Belgium,…
Read More...

Vertex Pharmaceuticals Incorporated announced the U.S. Food and Drug Administration (FDA) approved KALYDECO (ivacaftor) for use in children with cystic fibrosis (CF) ages 1 month to…
Read More...